Investors & Media
News
Sage Therapeutics to Present at Society for Neuroscience 2016 Annual Meeting
Below is the schedule for the presentations:
Date:
Poster Presentation
Time:
Location: Halls B-H,
Poster Number: 34.04 / E6
Title: Pharmacology
of the human ε subunit from the GABAA receptors
Date:
Poster Presentation Time: 1:00
p.m. -
Location: Halls B-H,
Poster Number: 407.11 / K17
Title: Neuroactive
steroids exhibit synergistic interactions with barbiturates at the GABAA
receptor in vitro and this impacts on activity in an animal model
of seizure
Date:
Poster Presentation Time: 8:00
a.m. -
Location: Halls B-H,
Poster Number: 497.10 / F21
Title: Positive
allosteric modulation of NMDA receptors ameliorate behavioral and
electrophysiological phenotypes in a pre-clinical model of
Smith-Lemli-Opitz Syndrome
Date:
Poster Presentation
Time: 8:00 a.m. -
Location: Halls
B-H,
Poster Number: 690.11 / L8
Title: Phenytoin
halts convulsions, but not electrographic seizure activity, in a rat
model of status epilepticus, whereas both are eliminated by next
generation neuroactive steroids
About
View source version on businesswire.com: http://www.businesswire.com/news/home/20161110006437/en/
Investor Contact:
paul.cox@sagerx.com
or
Media
Contact:
maureen.suda@sagerx.com
Source:
News Provided by Acquire Media